Qinnovativ Medtech announces a strategic collaboration with Keya Medical, the global leader in AI-powered FFR-CT technology, to drive international expansion in non-invasive cardiac diagnostics.
With FDA (U.S.), CE (Europe), and NMPA (China) approvals already in hand, Keya Medical has positioned itself as a leading standard in AI-powered cardiac diagnostics.
AI at the Forefront of Cardiac Care
Keya’s DeepVessel FFR technology is at the cutting edge of non-invasive coronary artery disease assessment, delivering precise, AI-driven analysis in minutes—a stark contrast to traditional FFR methods requiring invasive catheterization. As hospitals worldwide move toward cost-efficient, AI-enhanced workflows, Keya’s platform is proving indispensable.
Enter Qinnovativ Medtech, a firm specializing in market expansion and commercialization of next-gen healthcare technologies. With the company founder Nathan Qin joing Keya’s advisory board, Qinnovativ will spearhead Keya’s global scaling efforts, navigating the complex regulatory landscape and forging high-value commercial partnerships across key international markets.
The Global Play
With FFR-CT demand soaring amid a global push for early, non-invasive cardiac diagnostics, the Keya-Qinnovativ partnership is well-timed. Regulatory fast-tracking in Brazil and Japan will place Keya among the very few AI-driven cardiovascular imaging firms with near-total global market access.
“The future of cardiac imaging is AI-powered, and Keya Medical is leading that charge,” said Nathan Qin, Founder & Managing Partner at Qinnovativ Medtech. “With approvals secured in the U.S., Europe, and China, and imminent in Brazil and Japan, Keya is poised to transform how clinicians diagnose and manage coronary artery disease worldwide.”
While established players in AI-driven imaging continue to refine their offerings, Keya Medical’s full-stack regulatory approvals and best-in-class AI accuracy make it an outlier in a crowded space. With Qinnovativ’s expertise in scaling medical technology across borders, the partnership is set to accelerate Keya’s footprint in hospitals and imaging centers across North America, Europe, LATAM, Middle East and Asia-Pacific.
More info related to Keya please see under: https://www.keyamedical.com
Keya Medical PR: https://www.keyamedical.cn/blog/qinnovativ-medtech/
